Arvinas Inc (ARVN) financials

NASDAQ · Health Care

$7.86 -0.51% Close Oct 30, 2026 Live

Arvinas revenue and earnings by year

Arvinas's revenue was $263 million in the fiscal year to December 31, 2025, down 0.3% from the year before. Net income was -$80.8 million, -30.8% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 50.4% a year on average.

RevenueNet income
-$200M$0$200M
2016201720182019202020212022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 10 fiscal years

In millions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
Revenue263263791315426431487
Revenue growth-0.3%235.5%-40.3%145.1%106.9%-39.8%200.2%89.0%13.6%—
Operating income-119-250-402-263-188-121-52-44-25-16
Operating margin-45.1%-95.0%-511.5%-200.3%-351.5%-466.4%-119.8%-305.8%-326.7%-247.0%
Net income-81-199-367-283-191-119-70-41-24-14
Net margin-30.8%-75.5%-467.9%-215.0%-356.3%-460.6%-163.5%-289.6%-317.3%-215.2%
Diluted EPS-$1.14-$2.77-$6.62-$5.31-$3.82-$3.01-$2.14———
Free cash flow-276-261-351-280555-96-47-194-20

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open ARVN in Markets.

See also: ARVN valuation and P/E history · ARVN returns

No forecast, no recommendation. This page describes Arvinas Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.